What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications
- PMID: 33796265
- PMCID: PMC7970174
- DOI: 10.1177/2045125321991274
What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications
Abstract
Although psychiatric drug withdrawal syndromes have been recognized since the 1950s - recent studies confirm antidepressant withdrawal syndrome incidence upwards of 40% - medical information about how to safely go off the drugs has been lacking. To fill this gap, over the last 25 years, patients have developed a robust Internet-based subculture of peer support for tapering off psychiatric drugs and recovering from withdrawal syndrome. This account from the founder of such an online community covers lessons learned from thousands of patients regarding common experiences with medical providers, identification of adverse drug reactions, risk factors for withdrawal, tapering techniques, withdrawal symptoms, protracted withdrawal syndrome, and strategies to cope with symptoms, in the context of the existing scientific literature.
Keywords: antidepressant; deprescribing; discontinuation syndrome; iatrogenic; kindling; polypharmacy; post-acute withdrawal; psychotropic; tapering; withdrawal syndrome.
© The Author(s), 2021.
Conflict of interest statement
Conflict of interest statement: The author is founder and administrator of SurvivingAntidepressants.org, a website offering tapering information and volunteer peer support for withdrawal and protracted withdrawal syndrome from psychiatric drugs. SurvivingAntidepressants.org does not provide medical care, psychiatric diagnosis, or psychotherapy. Donations underwrite site expenses. The author does not receive any compensation, monetary or otherwise, for serving in this capacity.
Similar articles
-
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. doi: 10.1002/14651858.CD013495.pub2. Cochrane Database Syst Rev. 2021. PMID: 33886130 Free PMC article.
-
The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?Ther Adv Psychopharmacol. 2021 Jan 17;11:2045125320981174. doi: 10.1177/2045125320981174. eCollection 2021. Ther Adv Psychopharmacol. 2021. PMID: 33520155 Free PMC article.
-
Designing withdrawal support services for antidepressant users: Patients' views on existing services and what they really need.J Psychiatr Res. 2023 May;161:298-306. doi: 10.1016/j.jpsychires.2023.03.013. Epub 2023 Mar 20. J Psychiatr Res. 2023. PMID: 36989904
-
Psychotropic Drug Withdrawal and Holistic Tapering Strategies: A Case Series.Adv Mind Body Med. 2019 Fall;33(4):4-16. Adv Mind Body Med. 2019. PMID: 32738037
-
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications.Psychother Psychosom. 2020;89(5):283-306. doi: 10.1159/000506868. Epub 2020 Apr 7. Psychother Psychosom. 2020. PMID: 32259826 Review.
Cited by
-
The experiences of 585 people when they tried to withdraw from antipsychotic drugs.Addict Behav Rep. 2022 Mar 17;15:100421. doi: 10.1016/j.abrep.2022.100421. eCollection 2022 Jun. Addict Behav Rep. 2022. PMID: 35434245 Free PMC article.
-
Priorities for future research on reducing and stopping psychiatric medicines using a James Lind Alliance priority setting partnership: The PROTECT study protocol.HRB Open Res. 2022 Nov 10;5:72. doi: 10.12688/hrbopenres.13649.1. eCollection 2022. HRB Open Res. 2022. PMID: 37636245 Free PMC article.
-
Prevalence, trends, and individual patterns of long-term antidepressant medication use in the adult Swiss general population.Eur J Clin Pharmacol. 2023 Nov;79(11):1505-1513. doi: 10.1007/s00228-023-03559-4. Epub 2023 Sep 5. Eur J Clin Pharmacol. 2023. PMID: 37668659 Free PMC article.
-
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study.Ther Adv Psychopharmacol. 2021 Aug 27;11:20451253211039327. doi: 10.1177/20451253211039327. eCollection 2021. Ther Adv Psychopharmacol. 2021. PMID: 34471516 Free PMC article.
-
The missing link? Pharmacists' perspectives on discontinuation of long-term antidepressants: a qualitative study.Ther Adv Psychopharmacol. 2025 Apr 27;15:20451253251333977. doi: 10.1177/20451253251333977. eCollection 2025. Ther Adv Psychopharmacol. 2025. PMID: 40302918 Free PMC article.
References
-
- Dilsaver SC, Greden JF. Antidepressant withdrawal phenomena. Biol Psychiatry 1984; 19: 237–256. - PubMed
-
- Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addict Behav 2019; 97: 111–121. - PubMed
-
- Jha MK, Rush AJ, Trivedi MH. When discontinuing SSRI antidepressants is a challenge: management tips. Am J Psychiatry 2018; 175: 1176–1184. - PubMed
-
- Fava GA, Gatti A, Belaise C, et al. Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom 2015; 84: 72–81. - PubMed
-
- Benzobuddies.org. Benzodiazepine withdrawal support and information, https://web.archive.org/web/20041009112234/http://www.benzobuddies.org/ (2004, accessed 27 December 2020).
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous